No Applications Submitted Yet For Cannabis-Based Products In Malta

No applications have yet been filed to license any cannabis-based products in Malta, according to the Malta Medicines Authority.

The news comes after the Medicines Authority said it was listening to stakeholders regarding medicinal use of cannabis. The authority also said it was "months" away from recommending approval of Sativex®, a CBD spray that can be used in patients with multiple sclerosis. Sativex® is already licensed in the EU, in countries such as Italy, the UK and Ireland. 

"We have not yet recommended the licensing of Sativex® as a medicinal product but we have no objection to do so if an application comes in and all the requirements are met," said a spokesman for the MMA.

The authority also said that use of other products could be considered in exceptional circumstances. This would occur if a specialist in any of the areas of neurology, oncology, radiotherapy, psychiatry, anaesthetics and intensive care medicine were to file a request to the Superintendent of...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.